RNS Number:5995A
Lombard Medical Technologies PLC
20 July 2007



   
                                                                  

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES


(1). Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:

LOMBARD MEDICAL TECHNOLOGIES PLC


2. Reason for the notification (please state Yes/No):                      (  )

An acquisition or disposal of voting rights:                               (YES)

An acquisition or disposal of financial instruments which may result 
in the acquisition of shares already issued to which voting rights are 
attached:                                                                  (NO)

An event changing the breakdown of voting rights:                          (NO)

Other (please specify) :                                                   (NO)

change in issued capital 
 
3. Full name of person(s) subject to the notification obligation:

JENNISON HEALTH SCIENCES FUND, A SERIES OF THE JENNISON SECTOR FUNDS, INC.
(DIRECT OWNER); JENNISON ASSOCIATES LLC (INVESTMENT MANAGER WITH VOTING
CONTROL); OTHER PERSONS NAMED IN ITEM 9 (CHAIN OF CONTROLLING UNDERTAKINGS);
PRUDENTIAL FINANCIAL, INC. (ULTIMATE PARENT);
 

4. Full name of shareholder(s) (if different from 3.):


 

5. Date of the transaction and date on which the threshold is crossed or reached
if different):

JULY 10, 2007
 

6. Date on which issuer notified:


JULY 19, 2007

7. Threshold(s) that is/are crossed or reached:


5% 



8. Notified details:



A: Voting rights attached to shares

 
Class/type of shares            Situation previous to  
if possible using the           the Triggering         
ISIN CODE                       transaction        
                       Number of shares       Number of voting Rights 


ORDINARY SHARES                0                0
 


                     Resulting situation after the triggering transaction 
 
Class/type of shares Number of shares  Number of voting rights    % of voting rights  
if possible using                                                                 
the ISIN CODE        

ORDINARY SHARES      4,000,000         Direct      Indirect          Direct    Indirect                   
                                       4,000,000*    0                 8%       0%

*JENNISON HEALTH SCIENCES FUND HAS DIRECT OWNERSHIP OF THESE VOTING RIGHTS. 
JENNISON ASSOCIATES LLC AS INVESTMENT MANAGER OF THE FUND HAS INDIRECT 
OWNERSHIP OF THESE VOTING RIGHTS UNDER DTR 5.2.1(e) AND (h). THE OTHER
PERSONS MAKING NOTIFICATION, WHICH ARE CONTROLLING UNDERTAKINGS OF 
JENNISON ASSOCIATES LLC, HAVE INDIRECT OWNERSHIP UNDER DTR 5.2.1(e)
               
B: Financial Instruments             


Resulting situation after the triggering transaction 

Type of     Expiration Date  Exercise/Conversion Number of voting     % of voting     
financial                    Period/ Date        rights that may be   rights          
instrument                                       acquired if the                      
                                                 instrument is                        
                                                 exercised/                           
                                                 converted.                           

 

Total (A+B)
Number of voting rights       % of voting rights 

4,000,000                          8%
 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

PRUDENTIAL FINANCIAL, INC. OWNS 100% OF PRUDENTIAL ASSET MANAGEMENT
HOLDING COMPANY LLC, WHICH OWNS 100% OF PRUDENTIAL INVESTMENT MANAGEMENT, INC., 
WHICH OWNS 100% OF THE EQUITY INTERESTS IN JENNISON ASSOCIATES LLC. 
JENNISON ASSOCIATES LLC IS THE INVESTMENT MANAGER OF JENNISON HEALTH
SCIENCES FUND AND HAS INDIRECT VOTING POWER OVER SHARES OWNED BY THE FUND.
THIS NOTIFICATION BY A PARENT UNDERTAKING IS INTENDED TO COVER THE
NOTIFICATION OBLIGATIONS OF THE CONTROLLED UNDERTAKINGS.



Proxy Voting:

 
10. Name of the proxy holder: NOT APPLICABLE


 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 

13. Additional information:


 

14. Contact name:


MIRRY HWANG, CHIEF LEGAL OFFICER


15. Contact telephone number:

+1 (212) 833-0589


 




                      This information is provided by RNS
            The company news service from the London Stock Exchange

END

HOLURRARBSRBUAR

Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Lombard Medical Technologies Charts.
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Lombard Medical Technologies Charts.